Oculis (OCS) News Today $22.74 +0.53 (+2.39%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Here's What Could Help Oculis Holding AG (OCS) Maintain Its Recent Price StrengthJanuary 13, 2025 | msn.comOculis (NASDAQ:OCS) Sets New 1-Year High - Time to Buy?Oculis (NASDAQ:OCS) Hits New 12-Month High - Should You Buy?January 13, 2025 | marketbeat.comOculis (NASDAQ:OCS) Shares Gap Up - Still a Buy?January 12, 2025 | americanbankingnews.comOculis (NASDAQ:OCS) Shares Gap Up - Should You Buy?Oculis (NASDAQ:OCS) Shares Gap Up - What's Next?January 10, 2025 | marketbeat.comOculis Holding’s OCS-05 Receives Buy Rating Amid Promising Clinical Data and Regulatory AdvancementsJanuary 9, 2025 | markets.businessinsider.comOculis (NASDAQ:OCS) Sees Large Volume Increase - Here's WhyOculis (NASDAQ:OCS) Sees Large Volume Increase - What's Next?January 8, 2025 | marketbeat.comPromising Clinical Results and Market Potential Drive Buy Rating for Oculis HoldingJanuary 7, 2025 | markets.businessinsider.comOculis Trial Shows Potential for Optical Neuroprotective TherapyJanuary 7, 2025 | finance.yahoo.comOculis price target raised to $31 from $23 at BofAJanuary 7, 2025 | markets.businessinsider.comOculis' (OCS) "Buy" Rating Reiterated at Chardan CapitalChardan Capital reissued a "buy" rating and issued a $28.00 target price on shares of Oculis in a research report on Tuesday.January 7, 2025 | marketbeat.comOculis' (OCS) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $30.00 target price on shares of Oculis in a research report on Monday.January 6, 2025 | marketbeat.comOculis (NASDAQ:OCS) Hits New 52-Week High - Here's What HappenedOculis (NASDAQ:OCS) Reaches New 1-Year High - Here's What HappenedJanuary 6, 2025 | marketbeat.comOculis’ acute optic neuritis therapy trial meets primary endpointJanuary 6, 2025 | finance.yahoo.comOculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective TherapyJanuary 6, 2025 | globenewswire.comOculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective TherapyJanuary 6, 2025 | globenewswire.comOculis Publishes Notification of Major Changes in Voting RightsJanuary 4, 2025 | finance.yahoo.comOculis (NASDAQ:OCS) Shares Gap Up - Here's What HappenedOculis (NASDAQ:OCS) Shares Gap Up - Should You Buy?January 3, 2025 | marketbeat.comOculis (NASDAQ:OCS) Sees Unusually-High Trading Volume - Here's WhyOculis (NASDAQ:OCS) Sees Unusually-High Trading Volume - What's Next?December 13, 2024 | marketbeat.comOculis Publishes Notifications of Transactions by Persons Discharging Managerial ResponsibilitiesDecember 6, 2024 | globenewswire.comOculis Holding AG (NASDAQ:OCS) Short Interest UpdateOculis Holding AG (NASDAQ:OCS - Get Free Report) was the target of a significant increase in short interest in the month of November. As of November 15th, there was short interest totalling 24,300 shares, an increase of 54.8% from the October 31st total of 15,700 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 49,800 shares, the short-interest ratio is currently 0.5 days.November 29, 2024 | marketbeat.comOculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely AssociatedNovember 29, 2024 | globenewswire.comOculis Publishes Notification of Transaction by Person Discharging Managerial ResponsibilitiesNovember 27, 2024 | globenewswire.comOculis (NASDAQ:OCS) Shares Up 3.8% - Here's WhyOculis (NASDAQ:OCS) Stock Price Up 3.8% - Still a Buy?November 19, 2024 | marketbeat.comBank of America Securities Sticks to Its Buy Rating for Oculis Holding (OCS)November 14, 2024 | markets.businessinsider.comIs Oculis Holding (OCS) Top Performing European Stock Heading into 2025?November 14, 2024 | msn.comOculis to Present at the Stifel 2024 Healthcare ConferenceNovember 13, 2024 | globenewswire.comOculis to Present at the Stifel 2024 Healthcare ConferenceNovember 13, 2024 | globenewswire.comOculis Holding’s Promising Clinical Advancements and Market Potential Drive Buy RatingNovember 11, 2024 | markets.businessinsider.comOculis Holding: Promising Pipeline and Market Potential Support Buy RatingNovember 11, 2024 | markets.businessinsider.comOculis (NASDAQ:OCS) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $30.00 target price on shares of Oculis in a report on Monday.November 11, 2024 | marketbeat.comOculis Holding AG Reports Q3 2024 Financial ProgressNovember 9, 2024 | markets.businessinsider.comOculis Holding’s Financial Struggles Amid Asset GrowthNovember 7, 2024 | markets.businessinsider.comOculis Reports Q3 2024 Financial Results and Provides Company UpdatesNovember 7, 2024 | globenewswire.comOculis Reports Q3 2024 Financial Results and Provides Company UpdatesNovember 7, 2024 | globenewswire.comOculis (OCS) Scheduled to Post Quarterly Earnings on ThursdayOculis (NASDAQ:OCS) will be releasing earnings before the market opens on Thursday, November 7, Zacks reports.November 5, 2024 | marketbeat.comOculis (NASDAQ:OCS) Hits New 52-Week High - What's Next?Oculis (NASDAQ:OCS) Reaches New 52-Week High - Here's WhyNovember 4, 2024 | marketbeat.comOculis: Lack Of Coverage Only Real Risk For This Solid CompanyNovember 4, 2024 | seekingalpha.comabrdn plc Sells 279,879 Shares of Oculis Holding AG (NASDAQ:OCS)abrdn plc cut its stake in Oculis Holding AG (NASDAQ:OCS - Free Report) by 25.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 820,553 shares of the company's stock after selling 279,879 shares during the perioNovember 3, 2024 | marketbeat.comOculis (NASDAQ:OCS) Sees Strong Trading Volume - What's Next?Oculis (NASDAQ:OCS) Sees Large Volume Increase - Should You Buy?November 1, 2024 | marketbeat.comOculis Holding AG's (NASDAQ:OCS) largest shareholders are individual investors with 56% ownership, institutions own 39%October 31, 2024 | finance.yahoo.comOculis (NASDAQ:OCS) Sets New 1-Year High - What's Next?Oculis (NASDAQ:OCS) Sets New 12-Month High - Should You Buy?October 28, 2024 | marketbeat.comShort Interest in Oculis Holding AG (NASDAQ:OCS) Grows By 133.7%Oculis Holding AG (NASDAQ:OCS - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 45,100 shares, an increase of 133.7% from the September 30th total of 19,300 shares. Approximately 0.2% of the shares of the company are short sold. Based on an average daily volume of 36,400 shares, the days-to-cover ratio is presently 1.2 days.October 27, 2024 | marketbeat.comOculis (NASDAQ:OCS) Shares Gap Down - What's Next?Oculis (NASDAQ:OCS) Shares Gap Down - Here's What HappenedOctober 25, 2024 | marketbeat.comHC Wainwright Reaffirms Buy Rating for Oculis (NASDAQ:OCS)HC Wainwright reissued a "buy" rating and set a $30.00 price target on shares of Oculis in a research note on Wednesday.October 23, 2024 | marketbeat.comOculis Holding Gains ‘Buy’ Rating Amid Promising Clinical Trial Advancements and Pipeline PotentialOctober 23, 2024 | markets.businessinsider.comOculis (NASDAQ:OCS) Reaches New 52-Week High - Time to Buy?Oculis (NASDAQ:OCS) Sets New 1-Year High - Here's What HappenedOctober 22, 2024 | marketbeat.comOculis accelerates patient enrollment for both Phase 3 DIAMOND trialsOctober 22, 2024 | markets.businessinsider.comOculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program CommitteesOctober 21, 2024 | globenewswire.comOculis (NASDAQ:OCS) Trading Up 4.8% - Here's What HappenedOculis (NASDAQ:OCS) Trading 4.8% Higher - Still a Buy?October 21, 2024 | marketbeat.comOculis Accelerates Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema and Expands its DIAMOND Program CommitteesOctober 21, 2024 | globenewswire.com Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCS and its competitors with MarketBeat's FREE daily newsletter. Email Address OCS Media Mentions By Week OCS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OCS News Sentiment▼-0.070.44▲Average Medical News Sentiment OCS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OCS Articles This Week▼02▲OCS Articles Average Week Get Oculis News Delivered to You Automatically Sign up to receive the latest news and ratings for OCS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRNX News Today APLS News Today PTCT News Today RNA News Today RYTM News Today IMVT News Today ACAD News Today VCEL News Today XENE News Today MLTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OCS) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
